Microscope peers into eczema skin changes during new drug treatment
NCT ID NCT07568665
First seen May 10, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study is looking at 15 adults with moderate-to-severe eczema (atopic dermatitis) who are starting treatment with tralokinumab. Researchers will use a special, non-invasive microscope called reflectance confocal microscopy to take detailed pictures of the skin's structure. The goal is to see how the skin changes at a cellular level during treatment, which could help doctors better understand how the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopitaux Drome NOrd
RECRUITINGRomans-sur-Isère, Drôme, 26100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.